Liver News and Research

RSS

Cornell study finds existing drug could boost liver cancer immunotherapy

Immunotherapy – which activates the body's own immune system to kill cancer cells – has not worked well against a rare and fatal liver cancer, but a new Cornell University study finds an existing FDA-approved drug may allow the immunotherapy to fight the cancer as intended, opening the door to a potential treatment.

17 Feb 2026

Do cocoa flavanols influence heart and fatty liver risk factors?

A recent Nutrients review examined whether cocoa-rich dark chocolate influences cardiovascular and metabolic dysfunction-associated steatotic liver disease risk factors through antioxidant, anti-inflammatory, and endothelial effects. Evidence suggests modest improvements in biomarkers, but most data come from short-term studies, so definitive clinical benefits remain unproven.

16 Feb 2026

Machine learning model demonstrates insulin resistance as a risk factor for 12 types of cancer

Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - is one of the fundamental causes of diabetes.

16 Feb 2026

Parenting style shapes adolescent alcohol and drug use

"Like father, like son? Can parenting styles break the intergenerational pattern of alcohol and drug use?" A group of Brazilian researchers analyzed data on the behavior of 4,280 adolescents and their guardians based on this question, arriving at two important conclusions.

13 Feb 2026

Study explores whether a bidirectional causal link exists between MASLD and sarcopenia

Metabolic dysfunction-associated steatotic liver disease (MASLD) and sarcopenia frequently coexist, yet their causal relationship and underlying mechanisms remain poorly defined.

13 Feb 2026

Siemens Healthineers and Mayo Clinic expand partnership to fight neurodegenerative disease, cancer

Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors.

13 Feb 2026

RFK Jr. made promises in order to become health secretary. He’s broken many of them.

One year after taking charge of the nation’s health department, Health and Human Services Secretary Robert F. Kennedy Jr. hasn’t held true to many of the promises he made while appealing to U.S. senators concerned about the longtime anti-vaccine activist’s plans for the nation’s care.

13 Feb 2026

Human insight and AI advance prostate cancer treatment

Today, many men must choose between life-altering prostate removal or careful long-term monitoring. The EU-funded ROBIOSPY Project offers an intermediate option: precise needle-based diagnostics and targeted therapy powered by AI-driven robotics.

12 Feb 2026

Aligning overnight fasting with sleep improves heart health

A new Northwestern Medicine study has personalized overnight fasting by aligning it with individuals' circadian sleep-wake rhythm - an important regulator of cardiovascular and metabolic function - without changing their caloric intake.

12 Feb 2026

Routine aspirin therapy associated with lower rate of developing severe preeclampsia

Prescribing daily aspirin at the first prenatal visit to all pregnant patients was associated with an overall reduction in the development of severe preeclampsia, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting.

11 Feb 2026

Non-native birds drive widespread avian malaria transmission in Hawaii

New research on avian malaria, which has decimated Hawaii's beloved birds, explains how non-native birds play a key role in transmission and contribute to the widespread distribution of the disease.

10 Feb 2026

High-fat diets cause more damage to metabolic health than carbohydrates

In recent years, many media reports and social media influencers have emphasized the dangers of eating too many carbohydrates.

10 Feb 2026

University of Missouri launches first on-campus radiopharmaceutical clinical trial

In a major leap for cancer care at the University of Missouri, the School of Medicine and MU Health Care have launched their first clinical trial using a leading-edge therapy manufactured on campus at the university's research reactor.

10 Feb 2026

New guidance for the diagnosis and management of inherited hyperbilirubinemia

Inherited hyperbilirubinemia, encompassing Gilbert syndrome, Crigler-Najjar syndrome, Dubin-Johnson syndrome, and Rotor syndrome, represents a spectrum of disorders rooted in genetic defects affecting bilirubin metabolism and transport.

10 Feb 2026

Defective fat cells drive metabolic disease in lipodystrophy

Many people may have a dim view of their fat tissue, yet scientists have come to recognize adipose as a necessary and metabolically active organ, carrying out many vital functions within the body.

9 Feb 2026

Long-term omeprazole use linked to mineral imbalance risks

A study conducted in Brazil by researchers at the Federal University of São Paulo (UNIFESP) and the ABC Medical School (FMABC) warns that the prolonged use of proton pump inhibitors (PPIs) can impair nutrient absorption.

9 Feb 2026

Most statin side effects are not backed by trials

Research indicates that many statin therapy side effects are not supported by evidence, suggesting a need for revised labeling to improve treatment decisions.

9 Feb 2026

Novel neuroprotective drug improves recovery after acute ischemic stroke

Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who received a placebo, according to a preliminary late-breaking science presentation at the American Stroke Association's International Stroke Conference 2026.

7 Feb 2026

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of its Liver.SET™ library of liver-specific synthetic promoters.

5 Feb 2026

Large trials show statins rarely cause reported side effects

Cardiovascular disease results in around 20 million deaths worldwide and causes around a quarter of all deaths in the UK.

5 Feb 2026

Liver News and Research

Cornell study finds existing drug could boost liver cancer immunotherapy

Do cocoa flavanols influence heart and fatty liver risk factors?

Machine learning model demonstrates insulin resistance as a risk factor for 12 types of cancer

Parenting style shapes adolescent alcohol and drug use

Study explores whether a bidirectional causal link exists between MASLD and sarcopenia

Siemens Healthineers and Mayo Clinic expand partnership to fight neurodegenerative disease, cancer

RFK Jr. made promises in order to become health secretary. He’s broken many of them.

Human insight and AI advance prostate cancer treatment

Aligning overnight fasting with sleep improves heart health

Routine aspirin therapy associated with lower rate of developing severe preeclampsia

Non-native birds drive widespread avian malaria transmission in Hawaii

High-fat diets cause more damage to metabolic health than carbohydrates

University of Missouri launches first on-campus radiopharmaceutical clinical trial

New guidance for the diagnosis and management of inherited hyperbilirubinemia

Defective fat cells drive metabolic disease in lipodystrophy

Long-term omeprazole use linked to mineral imbalance risks

Most statin side effects are not backed by trials

Novel neuroprotective drug improves recovery after acute ischemic stroke

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies

Large trials show statins rarely cause reported side effects

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News